title: Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities.
abstract: BACKGROUND
  The New Zealand HPV publicly funded immunisation programme commenced in September 2008. Delivery through a school based programme was anticipated to result in higher coverage rates and reduced inequalities compared to vaccination delivered through other settings. The programme provided for on-going vaccination of girls in year 8 with an initial catch-up programme through general practices for young women born after 1 January 1990 until the end of 2010.
  
  
  OBJECTIVE
  To assess the uptake of the funded HPV vaccine through school based vaccination programmes in secondary schools and general practices in 2009, and the factors associated with coverage by database matching.
  
  
  METHODS
  Retrospective quantitative analysis of secondary anonymised data School-Based Vaccination Service and National Immunisation Register databases of female students from secondary schools in Auckland District Health Board catchment area. Data included student and school demographic and other variables. Binary logistic regression was used to estimate odds ratios and significance for univariables. Multivariable logistic regression estimated strength of association between individual factors and initiation and completion, adjusted for all other factors.
  
  
  RESULTS
  The programme achieved overall coverage of 71.5%, with Pacific girls highest at 88% and Maori at 78%. Girls higher socioeconomic status were more likely be vaccinated in general practice.
  
  
  CONCLUSIONS
  School-based vaccination service targeted at ethic sub-populations provided equity for the Maori and Pacific student who achieved high levels of vaccination.
authors.affiliation: Immunisation Advisory Centre, Department of General Practice & Primary Health Care, University of Auckland, Auckland, New Zealand.
authors.forename: Tracey
authors.initials: T
authors.lastname: Poole
authors.forename: Felicity
authors.initials: F
authors.lastname: Goodyear-Smith
authors.forename: Helen
authors.initials: H
authors.lastname: Petousis-Harris
authors.forename: Natalie
authors.initials: N
authors.lastname: Desmond
authors.forename: Daniel
authors.initials: D
authors.lastname: Exeter
authors.forename: Leah
authors.initials: L
authors.lastname: Pointon
authors.forename: Ranmalie
authors.initials: R
authors.lastname: Jayasinha
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D017589:Immunization Programs; D030361:Papillomavirus Infections / Q000276:immunology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D012189:Retrospective Studies; D014611:Vaccination / Q000706:statistics & numerical data
chemical_list: D053918:Papillomavirus Vaccines